Highly Pathogenic Avian Influenza (HPAI)
FDA’s Response to Ensure Continued Effectiveness of Federal-State Milk Safety System
Topic Paragraphs
Featured Topics
Know When and How to Use Antibiotics, and When to Skip Them
Antibiotics are powerful medications that save countless lives every day. But they’re not the answer for every illness.
FDA Modernization Efforts for Establishing a Unified Human Foods Program
The unified Human Foods Program, a new model and name for field operations and other modernization efforts are now in effect.
Recent Press Announcements
Recalls, Market Withdrawals, & Safety Alerts
Alerting you to the latest recalls of potentially unsafe FDA-regulated products gathered from press releases and other public notices. Not all recalls have press releases or are posted on this website.
Dec 16
GNMART INC Issues Voluntary Nationwide Recall of Force Forever Due to Undeclared Drug Ingredients Diclofenac and Dexamethasone
Dietary Supplements
Dec 13
Palermo Villa, Inc. Issues Recall for 1,728 Connie’s Thin Crust Cheese Frozen Pizzas Due to Possible Plastic Contaminant
Food & Beverages
Dec 13
Motivate Me Ashley, LLC is Recalling VidaSlim Brand 90-Day, 30-day and 7-Day Original Root, Root Plus, and Root Capsules & VidaSlim Hot Body Brew Due to the Presence of Yellow Oleander in the Products
Food & Beverages
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
Youth Tobacco Product Use Continues to Decline as FDA Actions Build Momentum
FDA’s ongoing efforts serve to make tobacco-related disease and death part of our nation’s past, ensuring a healthier future for our youth.
Upholding Public Trust: FDA Office of Criminal Investigations’ Crucial Role in Bringing Drug Criminals to Justice
OCI investigators have been conducting and coordinating criminal investigations of suspected illegal activities involving FDA-regulated products.
One Health - Optimal Public Health Outcomes for Humans and Animals in Our Shared Environment
FDA collaborates with stakeholders across disciplines and sectors to promote the health of humans, animals, and the environment.
Recently Published Guidances
Dec 13
Technical Specifications for Submitting Clinical Trial Data Sets for Treatment of Noncirrhotic Nonalcoholic Steatohepatitis (NASH)
Drugs
Dec 11
Guidance for Industry: Registration and Listing of Cosmetic Product Facilities and Products
Cosmetics
Dec 06
Standardized Format for Electronic Submission of NDA and BLA Content for the Planning of Bioresearch Monitoring (BIMO) Inspections for CDER Submissions Guidance for Industry
Biologics, Drugs